Ultrasound Evaluation of Therapeutic Response to Tofacitinib and Upadacitinib in Patients with Rheumatoid Arthritis-Real-Life Clinical Data.

Biomedicines · 2025 · PMC12190055 · PMID 40564058

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although tofacitinib trends appeared to be more predictable, both sets of measurements showed a clear trend—lower echography scores corresponded to lower disease state scores, which appeared to be significant.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.